(SAN DIEGO and ADELAIDE January 26,2022) BioCina, a leading contract development and manufacturing organization (CDMO) announces the appointment of Rick Hancock, Chairman of the Board. Hancock, with over 35 years of experience in life sciences, has held various board, executive and operational positions, developing expertise in cGMP manufacturing including plasmids, regulatory affairs, R & D, and operational […]
SA’s own needle-free Covid vaccine to start human trials
/in UncategorizedJune 20, 2022 Published in Sunday Mail, by Brad Crouch Excerpts copied below. Read the full article in Sunday Mail at the link at the bottom of the page. A new Covid-19 vaccine designed and manufactured in Adelaide starts human trials this week with potential to become a major export earner – and it doesn’t […]
Plasmid DNA Manufacturing- Insights from BioProcess International 2022
/in BlogThe widespread use of pDNA in cell and gene therapy (CGT) is driving increasing demand—and it’s no surprise it was one of the hottest topics at recent events including the recent BioProcess International (BPI) conference, what’s known as the largest bioprocessing event in the world. Sessions covering topics as diverse as cell and gene therapy, […]
PR Release – BioCina announces opening of new GMP plasmid DNA manufacturing suite
/in UncategorizedBioCina: Developing technologies to support the next generation of mRNA-based therapies
/in UncategorizedJune 1, 2022 Published on Success Stories austrade.gov.au Australian biologics manufacturer BioCina has plans to further develop its state-of-the-art facility to enable it to make the next generation of mRNA vaccines and other mRNA-based therapies possible. Backed by Australian Government financial support, BioCina is partnering with the University of Adelaide and US-based Cytiva to speed […]
PR Release – BioCina awarded Grant to advance RNA vaccines and therapeutics
/in Uncategorized(SAN DIEGO and ADELAIDE April 5, 2022) BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it has been awarded a $3.0m AUD grant under the Federal Government’s Cooperative Research Centres Projects (CRC-P) Grants scheme to fund work with its industry partners to further develop RNA vaccines and therapeutics. The grant has […]
Behind the doors of the bacterial factory
/in UncategorizedPublished in Cosmos Magazine By Ellen Phiddian Excerpts copied below. Read the full article in Cosmos Magazine at the link at the bottom of the page. BioCina’s pharmaceutical manufacturing plant, in Adelaide, is Australia’s only internationally certified microbial fermentation operation – and a lesson in keeping it clean. So how do they do it? Cosmos […]
Home-grown mRNA: inside the Adelaide facility that can make it
/in UncategorizedPublished in Cosmos Magazine Excerpts copied below. Read the full article in Cosmos Magazine at the link at the bottom of the page. Cosmos takes a look at BioCina’s pharmaceutical manufacturing process. While Moderna has announced it will be making mRNA vaccines on Australian shores by 2024, there are places that could already be doing parts of […]
PR Release – Rick Hancock named as Board Chairman for BioCina
/in Uncategorized(SAN DIEGO and ADELAIDE January 26,2022) BioCina, a leading contract development and manufacturing organization (CDMO) announces the appointment of Rick Hancock, Chairman of the Board. Hancock, with over 35 years of experience in life sciences, has held various board, executive and operational positions, developing expertise in cGMP manufacturing including plasmids, regulatory affairs, R & D, and operational […]
PR Release – BioCina expands expertise of Board of Directors with new member Sven Lee
/in Uncategorized(San Diego, June 30, 2021) BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics announces today the appointment of Sven Lee to the Board of Directors. BioCina is recognized for delivering high-quality, cost effective microbial process development and manufacturing solutions, leveraging a team of multi-disciplinary […]
PR Release – BioCina officially opens full-service CDMO in Adelaide, Australia, including mRNA and pDNA cGMP manufacturing
/in Uncategorized(SAN DIEGO and ADELAIDE, November 30, 2021) BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the official opening of its new biologics manufacturing facility in Adelaide, Australia. The official opening for the research, development and manufacturing biologic plant in Adelaide […]